Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2017

Zhu Gang-Zhi, Yang Yong-Long, Zhang Yan-Jiao, Liu Wei, Li Mu-Peng, Zeng Wen-Jing, Zhao Xie-Lan, Chen Xiao-Ping

Abstract excerpt

BACKGROUND/AIMS: Acute myeloid leukemia (AML) is a heterogeneous clonal disease and patients with AML who harbor an FMS-like tyrosine kinase 3 (FLT3) mutation present several dilemmas for the clinician. This study aims to identify novel targets for explaining the dilemmas. METHODS: We analyzed four microarray gene expression profiles to investigate changes in whole genome expression associated with FLT3-ITD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Proteins
Share to Cytoskeletal Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Glycophorins

Share to Kaplan-Meier Estimate

Share to Molecular Chaperones

Share to Proportional Hazards Models

Share to Protein Interaction Maps

Source

Identifiers

PMID: 28793301
DOI: 10.1159/000479837

Genes

FLT3
AHSP
EPB42
GYPC
HEMGN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia.PMID 28793301Read ↗

Upregulation of FHL1, SPNS3, and MPZL2 predicts poor prognosis in pediatric acute myeloid leukemia patients with FLT3-ITD mutation.Semantic proximity Read ↗

Comprehensive Gene Expression Analysis Reveals Factors that Influence the Progression, Occurrence and Development of AML-M4Semantic proximity Read ↗

Identification of Novel Genes Implicated in Acute Myeloid Leukemia Progression using Bioinformatics Analysis of Microarray DataSemantic proximity Read ↗

Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia.Semantic proximity Read ↗

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genesSemantic proximity Read ↗

High IFITM3 expression predicts adverse prognosis in acute myeloid leukemiaSemantic proximity Read ↗

Shared Genetic and Regulatory Mechanisms in Acute Myeloid Leukaemia and Blast Crisis Chronic Myeloid LeukaemiaSemantic proximity Read ↗

Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemiaSemantic proximity Read ↗

Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA databaseSemantic proximity Read ↗

Correlation of blood cell counts with mutant subtypes and impact prognosis in acute myeloid leukemia patients with FLT3 mutations.Semantic proximity Read ↗

Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalitiesSemantic proximity Read ↗

Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study GroupSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.